Trials / Completed
CompletedNCT04739462
SMS Maama Project COVID-19
mHealth for Improvement of Access to Maternal Health Services in the Era of COVID-19 Pandemic (SMS Maama Project)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 248 (actual)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The study's purpose is to demonstrate the ability of an mHealth platform as a feasible way of sharing information in a time of restricted movement in order to inform future studies.
Detailed description
The primary objective of this trial is to assess whether an mHealth platform increases maternal health knowledge in the areas of birth preparedness, pregnancy, and birth complications as measured by the pre- and post-surveys in comparison to routine antenatal care. The secondary objectives of this trial are; 1. To provide knowledge of COVID-19 symptoms, transmission, diagnosis, and treatment, in a time of social distancing and learning. 2. To improve access and linkages to maternal health services and information as well as provide appropriate referrals for pregnant females. 3. Inform the adoption of mHealth into future health delivery plans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | mHealth Platform | All participants randomized to the intervention group will receive 2-4 informational texts each week and will also receive interactive health screening questions throughout enrollment. A participant will also receive appointment reminder texts. All SMS text messages will be transmitted through a local organization known as The Medical Concierge Group (TMCG) via an electronic system that allows for bulk messaging. TMCG also staffs a 24-hour call line for those using TMCG services to call in for medical related questions. This call line is staffed by doctors and nurses; SMS Maama participants randomized to the interventional group will be able to access this call line free of charge as part of their enrollment in SMS Maama. |
Timeline
- Start date
- 2021-09-28
- Primary completion
- 2021-10-21
- Completion
- 2021-10-21
- First posted
- 2021-02-04
- Last updated
- 2022-04-14
Locations
2 sites across 2 countries: United States, Uganda
Source: ClinicalTrials.gov record NCT04739462. Inclusion in this directory is not an endorsement.